Unity BiotechnologyUNBX

13F holders, Q3 2025 (September 30)
6holders −29
1new positions
30sold out
$0.06avg. 13F price*

At the end of Q3 2025, 6 institutions reported holding Unity Biotechnology Inc. (UNBX) in their 13F filings, down 29 from Q2 2025. 1 opened new positions and 30 sold out. The largest holders were Osaic Holdings, Inc. ($831), XTX Topco Ltd ($782) and Steward Partners Investment Advisory, LLC ($56).

Company
Unity Biotechnology Inc.
CUSIP
91381U200
Latest filing quarter
Q3 2025

History

Number of 13F holders

010203040 Q1 2024: 40Q1 2024Q2 2024: 39Q2 2024Q3 2024: 38Q3 2024Q4 2024: 37Q4 2024Q1 2025: 40Q1 2025Q2 2025: 35Q2 2025Q3 2025: 6Q3 2025

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions1$782
Exits30$981K

All 13F filers, Q2 2025 → Q3 2025: 13,985 shares bought and 2,567,055 shares sold, net −2,553,070 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 6 holders

Osaic Holdings, Inc. 0.00% Reduce -0.8% 11,878 $831
XTX Topco Ltd 0.00% New 13,985 $782
Steward Partners Investment Advisory, LLC 0.00% Reduce -0.1% 1,000 $56
Ameritas Investment Partners, Inc. 0.00% No change 100 $6
AllSquare Wealth Management LLC 0.00% No change 55 $3
Simplex Trading, LLC 0.00% Reduce -10.4% 2,571 $0

"% of holder's portfolio" is UNBX's weight in each manager's 13F, not the share of Unity Biotechnology Inc. the manager owns.